Utility of serum squamous cell carcinoma antigen levels at the time of recurrent cervical cancer diagnosis in determining the optimal treatment choice

To investigate the utility of serum squamous cell carcinoma antigen (SCC-Ag) levels upon the diagnosis of recurrent cervical cancer for decision making in patient management. Clinical records from 167 cervical cancer patients who developed recurrence between April 1996 and September 2010 were review...

Full description

Saved in:
Bibliographic Details
Published in:Journal of gynecologic oncology 2013, 24(4), , pp.321-329
Main Authors: Shimura, Kotaro, Mabuchi, Seiji, Yokoi, Takeshi, Sasano, Tomoyuki, Sawada, Kenjirou, Hamasaki, Toshimitsu, Kimura, Tadashi
Format: Article
Language:English
Subjects:
Original
산부인과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To investigate the utility of serum squamous cell carcinoma antigen (SCC-Ag) levels upon the diagnosis of recurrent cervical cancer for decision making in patient management. Clinical records from 167 cervical cancer patients who developed recurrence between April 1996 and September 2010 were reviewed. A Cox proportional hazards regression model was used to investigate the prognostic significance of serum SCC-Ag levels at the time of recurrence. The effects of various salvage treatments on survival outcomes of recurrent cervical cancer were examined with respect to serum SCC-Ag levels. Serum SCC-Ag levels were elevated (>2.0 ng/mL) in 125 patients (75%) when recurrence was diagnosed. These patients exhibited significantly shorter postrecurrence survival than those with normal SCC-Ag levels (log-rank; p=0.033). Multivariate analyses revealed that an elevated serum SCC-Ag level was an independent prognostic factor for poor postrecurrence survival. In patients with SCC-Ag levels
ISSN:2005-0380
2005-0399
DOI:10.3802/jgo.2013.24.4.321